Compare BALY & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BALY | PACB |
|---|---|---|
| Founded | 2004 | 2000 |
| Country | United States | United States |
| Employees | N/A | 575 |
| Industry | Hotels/Resorts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 651.4M | 682.3M |
| IPO Year | N/A | 2010 |
| Metric | BALY | PACB |
|---|---|---|
| Price | $15.15 | $2.22 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $15.40 | $2.08 |
| AVG Volume (30 Days) | 77.8K | ★ 8.6M |
| Earning Date | 03-04-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,490,807,000.00 | $154,584,000.00 |
| Revenue This Year | $6.47 | $4.28 |
| Revenue Next Year | $6.48 | $12.50 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.36 | N/A |
| 52 Week Low | $8.46 | $0.85 |
| 52 Week High | $20.74 | $2.73 |
| Indicator | BALY | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 41.69 | 48.95 |
| Support Level | $14.63 | $2.09 |
| Resistance Level | $16.85 | $2.60 |
| Average True Range (ATR) | 0.77 | 0.20 |
| MACD | -0.14 | -0.00 |
| Stochastic Oscillator | 29.50 | 42.13 |
Ballys Corp is a gaming, hospitality, and entertainment company with a portfolio of casinos and resorts and a growing omnichannel presence. It provides customers with physical and interactive entertainment and gaming experiences, including traditional casino offerings, iGaming, online bingo, sportsbook, and free-to-play (F2P) games. The company owns and operates, several casinos across the United States, one golf course in New York, one horse racetrack in Colorado, and Aspers Casino in the United Kingdom. Its Interactive International division, an interactive gaming operator concentrated in Europe, operates a lottery management and services business. The company's reportable segments are Casinos and Resorts, which derive key revenue, International Interactive and North America Interactive.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.